OTCQB
SNANF

Sona Nanotech Inc

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

Sona Nanotech Inc Stock Price

Vitals

Today's Low:
$0.145
Today's High:
$0.145
Open Price:
$0.145
52W Low:
$0.049
52W High:
$0.264
Prev. Close:
$0.145
Volume:
0

Company Statistics

Market Cap.:
$13.35 million
Book Value:
0.026
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-28.33%
Return on Equity TTM:
-74.13%

Company Profile

Sona Nanotech Inc had its IPO on under the ticker symbol SNANF.

The company operates in the Healthcare sector and Diagnostics & Research industry. Sona Nanotech Inc has a staff strength of 0 employees.

Stock update

Shares of Sona Nanotech Inc opened at $0.15 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.15 - $0.15, and closed at $0.15.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Sona Nanotech Inc have increased by +6.62%.

Sona Nanotech Inc's Key Ratios

Sona Nanotech Inc has a market cap of $13.35 million, indicating a price to book ratio of 21.8563 and a price to sales ratio of 0.

In the last 12-months Sona Nanotech Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-948375. The EBITDA ratio measures Sona Nanotech Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Sona Nanotech Inc’s operating margin was 0% while its return on assets stood at -28.33% with a return of equity of -74.13%.

In Q1.3333333333333, Sona Nanotech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Sona Nanotech Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sona Nanotech Inc’s profitability.

Sona Nanotech Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.2627. Its price to sales ratio in the trailing 12-months stood at 0.

Sona Nanotech Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$3.60 million
Total Liabilities
$510944.00
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Sona Nanotech Inc ended 2024 with $3.60 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.60 million while shareholder equity stood at $2.43 million.

Sona Nanotech Inc ended 2024 with $0 in deferred long-term liabilities, $510944.00 in other current liabilities, in common stock, $-18672233.00 in retained earnings and $0 in goodwill. Its cash balance stood at $700962.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $653280.00.

Sona Nanotech Inc’s total current assets stands at $842867.00 while long-term investments were $0 and short-term investments were $6000.00. Its net receivables were $112154.00 compared to accounts payable of $397846.00 and inventory worth $0.

In 2024, Sona Nanotech Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Sona Nanotech Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.15
52-Week High
$0.264
52-Week Low
$0.049
Analyst Target Price
$

Sona Nanotech Inc stock is currently trading at $0.15 per share. It touched a 52-week high of $0.264 and a 52-week low of $0.264. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.16 and 200-day moving average was $0.13 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 1859.8% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Sona Nanotech Inc

The stock symbol (also called stock or share ticker) of Sona Nanotech Inc is SNANF

The IPO of Sona Nanotech Inc took place on

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
$11
0.09
+0.82%
$3.61
0.4
+12.46%
$75.08
-4.3
-5.42%
$0.16
0
0%
$9.39
-0.24
-2.49%
$1.6
-0.1
-5.88%
EuroDry Ltd (EDRY)
$14
-0.1
-0.67%
$91.78
-3.17
-3.34%
$3.11
-0.13
-4.01%
$7.67
-1.81
-19.09%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Sona Nanotech Inc., a nanotechnology life sciences company, engages in developing various rapid diagnostic tests. Its products and services include COVID-19 Saliva Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; and contract services. The company is also involved in developing pre-clinical targeted hyperthermia therapy for colorectal cancer. Sona Nanotech Inc. was founded in 2014 and is based in Halifax, Canada.

Address

Purdy?s Wharf Tower II, Halifax, NS, Canada, B3J 3R7